PortfoliosLab logoPortfoliosLab logo
UTHR vs. TDW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UTHR vs. TDW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Tidewater Inc. (TDW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTHR achieves a 11.79% return, which is significantly lower than TDW's 47.18% return. Over the past 10 years, UTHR has outperformed TDW with an annualized return of 17.20%, while TDW has yielded a comparatively lower -7.55% annualized return.


UTHR

1D
-0.94%
1M
-3.58%
YTD
11.79%
6M
13.59%
1Y
67.18%
3Y*
33.59%
5Y*
25.53%
10Y*
17.20%

TDW

1D
2.57%
1M
-8.40%
YTD
47.18%
6M
30.31%
1Y
71.17%
3Y*
15.94%
5Y*
38.88%
10Y*
-7.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. TDW - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
11.79%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
TDW
Tidewater Inc.
47.18%-7.68%-24.13%95.69%244.07%23.96%-55.14%0.78%-21.60%-77.81%

Correlation

The correlation between UTHR and TDW is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jun 17, 1999

0.18

Fundamentals

Market Cap

UTHR:

$25.71B

TDW:

$3.69B

EPS

UTHR:

$27.00

TDW:

$6.00

PE Ratio

UTHR:

20.17

TDW:

12.38

PEG Ratio

UTHR:

0.66

TDW:

0.52

PS Ratio

UTHR:

8.19

TDW:

2.74

PB Ratio

UTHR:

4.36

TDW:

2.69

Total Revenue (TTM)

UTHR:

$3.17B

TDW:

$1.35B

Gross Profit (TTM)

UTHR:

$2.74B

TDW:

$314.74M

EBITDA (TTM)

UTHR:

$1.75B

TDW:

$489.31M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. TDW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 8686
Overall Rank
UTHR Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 8787
Sortino Ratio Rank
UTHR Omega Ratio Rank: 8787
Omega Ratio Rank
UTHR Calmar Ratio Rank: 8989
Calmar Ratio Rank
UTHR Martin Ratio Rank: 8989
Martin Ratio Rank

TDW
TDW Risk / Return Rank: 8080
Overall Rank
TDW Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
TDW Sortino Ratio Rank: 8080
Sortino Ratio Rank
TDW Omega Ratio Rank: 7777
Omega Ratio Rank
TDW Calmar Ratio Rank: 8282
Calmar Ratio Rank
TDW Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. TDW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Tidewater Inc. (TDW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTHRTDWDifference
Sharpe ratioReturn per unit of total volatility

+0.04

Sortino ratioReturn per unit of downside risk

+0.55

Omega ratioGain probability vs. loss probability

1.37

1.26

+0.11

Calmar ratioReturn relative to maximum drawdown

4.13

2.84

+1.29

Martin ratioReturn relative to average drawdown

10.54

6.23

+4.31

UTHR vs. TDW - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.36, which is comparable to the TDW Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of UTHR and TDW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UTHRTDWDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.36

1.31

+0.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.73

0.73

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

-0.11

+0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

-0.01

+0.40

Drawdowns

UTHR vs. TDW - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, smaller than the maximum TDW drawdown of -99.80%. Use the drawdown chart below to compare losses from any high point for UTHR and TDW.


Loading charts...

Drawdown Indicators


UTHRTDWDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-99.80%

+6.62%

Max Drawdown (1Y)

Largest decline over 1 year

-16.35%

-25.16%

+8.81%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

-70.35%

+37.35%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-70.35%

+37.35%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

-97.49%

+41.93%

Current Drawdown

Current decline from peak

-8.73%

-96.40%

+87.67%

Average Drawdown

Average peak-to-trough decline

-35.31%

-48.97%

+13.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.39%

11.46%

-5.07%

Volatility

UTHR vs. TDW - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 5.15%, while Tidewater Inc. (TDW) has a volatility of 10.15%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than TDW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTHRTDWDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.15%

10.15%

-5.00%

Volatility (6M)

Calculated over the trailing 6-month period

26.01%

31.12%

-5.11%

Volatility (1Y)

Calculated over the trailing 1-year period

49.84%

54.53%

-4.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.13%

53.43%

-18.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.07%

66.56%

-31.49%

Dividends

UTHR vs. TDW - Dividend Comparison

Neither UTHR nor TDW has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
TDW
Tidewater Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.12%0.00%0.00%0.04%0.00%14.37%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

UTHR vs. TDW - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Tidewater Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
781.50M
326.22M
(UTHR) Total Revenue
(TDW) Total Revenue
Values in USD except per share items

UTHR vs. TDW - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and Tidewater Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
82.9%
0
Portfolio components
UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

TDW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tidewater Inc. reported a gross profit of 0.00 and revenue of 326.22M. Therefore, the gross margin over that period was 0.0%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

TDW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tidewater Inc. reported an operating income of 58.98M and revenue of 326.22M, resulting in an operating margin of 18.1%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

TDW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tidewater Inc. reported a net income of 6.14M and revenue of 326.22M, resulting in a net margin of 1.9%.


Frequently Asked Questions


UTHR and TDW have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TDW has higher volatility (10.15%) compared to UTHR (5.15%). In terms of maximum drawdown, UTHR dropped -93.18% vs TDW's -99.80%.

UTHR currently has the higher Sharpe Ratio (1.36 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTHR and TDW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer